Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: A retrospective cohort study

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Berger, Ariel ^a   Sadosky, Alesia ^b   Dukes, Ellen ^b   Edelsberg, John ^a   Oster, Gerry ^a  

^a POLICY ANALYSIS INC PAI   (United States)

^b PFIZER INC   (United States)

Author keywords

Analgesia; Health services research; Nerve pain; Neuralgia; Peripheral neuropathies; Pharmacotherapy

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTITUSSIVE AGENT; ANTIULCER AGENT; BENZODIAZEPINE DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; DERMATOLOGICAL AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT; ANALGESIC AGENT; LIDOCAINE; LOCAL ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT;

ABSENTEEISM; ADULT; AGED; ARTICLE; BACKACHE; CARPAL TUNNEL SYNDROME; CONTROLLED STUDY; DRUG USE; FEMALE; GENERAL PRACTICE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEURITIS; NEUROPATHIC PAIN; PATIENT REFERRAL; PRESCRIPTION; UNITED KINGDOM; ANXIETY; CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; GASTROINTESTINAL DISEASE; HEALTH SERVICE; MIDDLE AGED; NEURALGIA; PERIPHERAL NEUROPATHY; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; UTILIZATION REVIEW;

ADULT; AGED; ANALGESICS; ANALGESICS, OPIOID; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; DEPRESSION; FEMALE; GASTROINTESTINAL DISEASES; GENERAL PRACTICE; GREAT BRITAIN; HEALTH SERVICES; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES;

EID: 84857714582     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-8     Document Type: Article

References (45)

1. Fields HL, Martin JB. Pain: pathophysiology and management. Harrison's Principles of Internal Medicine 1997, 55-58. United States of America: McGraw-Hill Companies, Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, 14, 3296080, 22423264.
2. Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms 1994, Seattle: IASP Press, 2.
3. National Collaborating Centre for Chronic Conditions Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). National Collaborating Centre for Chronic Conditions., http://www.nice.org.uk/nicemedia/pdf/CG66diabetesfullguideline.pdf
4. Attal N, Cruccu G, Haanpaa M, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006, 13:1153-1169. 10.1111/j.1468-1331.2006.01511.x, 17038030.
5. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: An overview of recent guidelines. Am J Med 2009, 122:S22-S32. 2821819, 19962493.
6. Attal N, Finnerup NB, . on behalf of the IASP Neuropathic Pain Special Interest Group (NeuPSIG) Pharmacological management of neuropathic pain. IASP 2010, 18:1-8. on behalf of the IASP Neuropathic Pain Special Interest Group (NeuPSIG).
7. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004, 5:143-149.
8. Berger A, Toelle T, Sadosky A, Dukes E, Edelsberg J, Oster G. Clinical and economic characteristics of patients with painful neuropathic disorders in Germany. Pain Practice 2009, 9:8-17. 10.1111/j.1533-2500.2008.00244.x, 19019057.
9. Lachaine J, Gordon A, Choiniere M, Collet JP, Dion D, Tarride JE. Painful neuropathic disorders: an analysis of the Regi de l'Assurance Maladie du Quebec database. Pain Res Manage 2007, 12:31-37.
10. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006, 122:156-162. 10.1016/j.pain.2006.01.030, 16545908.
11. Hall GC, Carroll D, McQuay HJ. Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005. BMC Fam Pract 2008, 9:26. 10.1186/1471-2296-9-26, 2413228, 18460194.
12. Gore M, Dukes E, Rowbotham DJ, Tai KS, Leslie D. Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings. Eur J Pain 2007, 11:652-664. 10.1016/j.ejpain.2006.10.004, 17126045.
13. World Health Organization Cancer Pain Relief 1996, Geneva, Switzerland, World Health Organization.
14. Allen RR. Neuropathic pain in the cancer patient. Neurol Clin 1998, 16:869-888. 10.1016/S0733-8619(05)70102-X, 9767067.
15. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988, 33:11-23. 10.1016/0304-3959(88)90198-4, 2454440.
16. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998, 280:1831-1836. 10.1001/jama.280.21.1831, 9846777.
17. Backonja MM. Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain 2000, 16:S67-S72. 10.1097/00002508-200006001-00012, 10870743.
18. Bonezzi C, Demartini L. Treatment options in postherpetic neuralgia. Acta Neurol Scand Suppl 1999, 173:25-35.
19. Brant JM. Cancer-related neuropathic pain. Nurse Pract Forum 1998, 9:154-162.
20. Berger A, Dukes E, Mercadante S, Oster G. Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain. Eur J Cancer Care 2006, 15:138-145.
21. Carrazana E, Mikoshiba I. Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manage 2003, 25:S31-S35. 10.1016/S0885-3924(03)00067-8, 12694990.
22. Cohen KL, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987, 147:1442-1444. 10.1001/archinte.1987.00370080078016, 3115210.
23. Farrar JT, Portenoy RK. Neuropathic cancer pain: the role of adjuvant analgesics. Oncology 2001, 15:1435-1445.
24. George RM, Ahmedzai SH. The management of neuropathic pain in cancer: clinical guidelines for the use of adjuvant analgesics. Indian J Cancer 2000, 37:4-9.
25. Green MW, Selman JE. Review article. The medical management of trigeminal neuralgia. Headache 1991, 31:588-592. 10.1111/j.1526-4610.1991.hed3109588.x, 1774173.
26. Hemstreet B, Lapointe M. Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy. Clin Ther 2001, 23:520-531. 10.1016/S0149-2918(01)80058-8, 11354388.
27. Kanner R. Diagnosis and management of neuropathic pain in patients with cancer. Cancer Invest 2001, 19:324-333. 10.1081/CNV-100102559, 11338889.
28. Katz N. Neuropathic pain in cancer and AIDS. Clin J Pain 2000, 16:S41-S48. 10.1097/00002508-200006001-00008, 10870739.
29. Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 1994, 35:S50-S53. 10.1002/ana.410350715, 8185299.
30. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995, 311:1047-1052. 10.1136/bmj.311.7012.1047, 2551361, 7580659.
31. Oster G, Berger A, Dukes E, Edelsberg J, McCarberg B. Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders. Am J Geriatr Pharmacother 2004, 2:163-170. 10.1016/j.amjopharm.2004.09.005, 15561648.
32. Ripamonti C, Dickerson ED. Strategies for the treatment of cancer pain in the new millennium. Drugs 2001, 61:955-977. 10.2165/00003495-200161070-00005, 11434451.
33. Thompson M, Bones M. Nontraditional analgesics for the management of postherpetic neuralgia. Clin Pharm 1985, 4:170-176.
34. Volmink J, Lancaster T, Gray S, Silagy C. Treatments for postherpetic neuralgia-a systematic review of randomized controlled trials. Fam Pract 1996, 13:84-91. 10.1093/fampra/13.1.84, 8671108.
35. SAS® Proprietary Software, Release 8.4. Cary, NC: SAS Institute Inc.
36. Gilron I, Watson DPN, Cahill CM, Moulin DE. Neuropathic pain: a practical guide for the clinician. CMAJ 2006, 175:265-275. 10.1503/cmaj.060146, 1513412, 16880448.
37. Mendell JR, Sahenk Z. Painful sensory neuropathy. N Eng J Med 2003, 348:1243-1255.
38. Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurologia 1998, 50:1837-1841.
39. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003, 348:1223-1232. 10.1056/NEJMoa021420, 12660386.
40. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Kamin M. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998, 50:1842-1846.
41. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to the mechanism of drug action. Pain 1999, 83:389-400. 10.1016/S0304-3959(99)00154-2, 10568846.
42. Hans G, Masquelier E, De Cock P. The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study. BMC Pub Health 2007, 170. doi:10.1186/1471-2458-7-170.
43. Chong MS, Bajwa ZH. Diagnosis and treatment of neuropathic pain. J Pain Symptom Manage 2003, 25:S4-S11. 10.1016/S0885-3924(03)00064-2, 12694987.
44. Williams H. Assessing, diagnosing and managing neuropathic pain. Nurs Times 2006, 102:22-24.
45. Forssell H, Tenovuo O, Silvoniemi P, Jaaskelainen SK. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. J Neurophysiol 2008, 99:2251-2263. 10.1152/jn.00794.2007, 18337368.